Abstract: The present invention relates to a substituted thiazolo[3,2-a] azepine derivative having inhibitory activity against angiotensin I converting enzyme and neutral endpeptidase and is represented by the following general formula (I): ##STR1##

Abstract: The present invention relates to a substituted thiazolo?3,2-a!azepine derivative having inhibitory activity against angiotensin I converting enzyme and neutral endpeptidase.

Abstract: A primary object is to provide a communication apparatus, in particular, its buffer memory which conforms mainly to specifications of SAE-J1850 or ISO-9141.

Abstract: The present invention relates to an amino acid derivative having an angiotensin I-converting enzyme inhibition activity, a vasopressin antagonism and an atrial natriuretic peptide hydrolase inhibition activity.This amino acid derivative is represented by the following general formula (I): ##STR1## wherein R.sup.1 represents a hydrogen atom or an acyl group; R.sup.2 represents a hydrogen atom, a lower alkyl group, a cycloalkyl group, an ary group which may have a substituent, a heteroaryl group which may have a substituent, an arylalkyl group which may have a substituent or a heteroarylalkyl group which may have a substituent;m and n represent each independently an integer of 0, 1 or 2 andJ represents a cyclic group having an angiotensin I-converting enzyme inhibition activity.

Abstract: An address detection circuit is formed in a pod so that the circuit generates a detection signal DET when an address signal specifying an address in the address area assigned to a newly-added circuit section is outputted from an evaluation MCU, and a disabling circuit 313 is formed in a port emulation circuit 31a so that the circuit 313 disables an input/output circuit 312 from being set to the input state by responding to the detection signal DET.

Abstract: A pyrrolidine compound having the following formula and a pharmacologically acceptable salt thereof is disclosed. It is useful in the pharmaceutical field. ##STR1## in which X is hydrogen, a halogen, or a lower alkyl, Y is --(CH2)n--, n being zero, 1 or 2, --S(O)p--, p being zero, 1 or 2, --O--, or --NH-- and R is phenyl, a substituent-having phenyl, naphtyl, a substituent-having naphthyl, a heteroaryl or a substituent-having heteroaryl.

Abstract: A complementary circuit device which cancels a latch-up phenomenon to return to normal operation includes a complementary circuit, a latch-up detection circuit and a reset circuit. The complementary circuit, which is normally started from a prescribed logic state in response to an initial power application of power to the circuit, is susceptible to erroneous restart when the same is resupplied with power immediately after occurrence of a latch-up phenomenon. The latch-up detection circuit detects a latch-up phenomenon occurring in the complementary circuit. The reset circuit resets the complementary circuit to the prescribed logic state in response to an output from the latch-up detection circuit. The complementary circuit is reset again to the prescribed state in a manner similar to the case of initial application of power. The invention facilitates a normal return to operation of a complementary circuit upon cancellation of the latch-up phenomenon.

Abstract: A digital remote control method in which interference among different devices is eliminated by the use of a custom code and an instruction code. In accordance with the invention, a transmission code is generated composed of an instruction code and a custom code, with the custom code and instruction code differing in the number of bits contained in each. The custom code is transmitted prior to the instruction code with an interval therebetween longer than the intervals between adjacent pulses, which intervals define data "0" and "1".

Abstract: A digital remote control apparatus for transmitting digital instruction signals to a controllable apparatus includes a transmitter for transmitting a coded digital instruction signal composed of a sequence of synchronization pulses having a predetermined period and data pulses each inserted between successive synchronization pulses at predetermined positions therein dependent upon whether the data pulses represents a "0" bit or a "1" bit. The receiving apparatus distinguishes between "0" and "1" bits by detecting the length of an interval between the leading edge of a synchronization pulse and the leading edge of an adjacent data pulse and determines the existence of noise if more than one data pulse is detected between successive synchronzation pulses.

Abstract: A display controller including a first ROM, a second ROM, a RAM, and an output circuit. The first ROM stores fixed data to be displayed on a fixed data area of a display screen. The RAM stores variable data to be displayed on a variable data area of the display screen and receives controlling addresses from the first ROM. The second ROM, under control of data from a preselected one of the first ROM or the RAM, outputs the display pattern data to be displayed on the display device. The output circuit latches the display pattern data and sends it to the display device at a predetermined timing.

Abstract: In a digital data transmission system, a transmitting device converts the data to be transmitted into a series of bits, in the form of data pulses. Each data pulse is positioned between successive synchronous pulses having a fixed time period, and each bit is represented by the time length between a data pulse and a preceding synchronous pulse or a succeeding synchronous pulse. The transmitting device transmits the series of the data pulses and the synchronous pulses. A receiving device receives the series of the data pulses and the synchronous pulses and decodes the same to read the data.

Abstract: A digital remote control device for use in a transmitter capable of transmitting an end code following each transmission code, which includes a counting circuit for counting the number of transmission operations performed by pressing a key or keys on the transmitter; and an end pulse changing circuit for changing a configuration of the end code such that the configuration corresponds to a count value counted by the counting circuit.

Abstract: Novel 1-(imidazo[1,2-a]pyridin-6-yl)-2-alkanone derivatives and (imidazo [1,2-a]pyridin-6-yl) acetaldehyde derivatives are provided. The novel derivatives are intermediates for the production of 5-(6-imidazo[1,2-a]pyridyl)pyridine derivatives which are useful as cardiotonics.

Abstract: 5-(6-Imidazo[1,2-a]pyridyl)pyridine derivatives represented by general formula: ##STR1## wherein X represents hydrogen atom or methyl group; Y represents cyano group, carboxamido group, hydrogen atom, amino group or a halogen atom; Z represents hydrogen atom or a lower alkyl group; W represents hydrogen atom or a lower alkyl group; R.sup.1 represents hydrogen atom, a lower alkyl group, phenyl group, a group shown by formula: --CH.sub.2 R.sup.4 in which R.sup.4 is a lower alkoxy group, or a group shown by formula: ##STR2## in which R.sup.5 and R.sup.6 are hydrogen atom or a lower alkyl group;R.sup.2 represents hydrogen atom or a halogen atom; and R.sup.3 represents hydrogen atom, a lower alkyl group or a halogen atom; or a tautomer thereof; and pharmacologically acceptable salts thereof are disclosed. The 5-(6-imidazo[1,2-a]pyridyl) pyridine derivatives are effective for treating congestive heart failures.

Abstract: 5-(6-Imidazo[1,2-a]pyridyl)pyridine derivatives represented by general formula: ##STR1## wherein X represents hydrogen atom or methyl group; Y represents cyano group, carboxamido group, hydrogen atom, amino group or a halogen atom; Z represents hydrogen atom or a lower alkyl group; W represents hydrogen atom or a lower alkyl group; R.sup.1 represents hydrogen atom, a lower alkyl group, phenyl group, a group shown by formula: --CH.sub.2 R.sup.4 in which R.sup.4 is a lower alkoxy group, or a group shown by formula: ##STR2## in which R.sup.5 and R.sup.6 are hydrogen atom or a lower alkyl group; R.sup.2 represents hydrogen atom or a halogen atom; and R.sup.3 represents hydrogen atom, a lower alkyl group or a halogen atom; or a tautomer thereof; and pharmacologically acceptable salts thereof are disclosed. The 5-(6-imidazo[1,2-a]pyridyl) pyridine derivatives are effective for treating congestive heart failures.

Abstract: 5-(6-Imidazo[1,2-a]pyridyl)pyridine derivatives represented by general formula: ##STR1## wherein X represents hydrogen atom or methyl group; Y represents cyano group, carboxamido group, hydrogen atom, amino group or a halogen atom; Z represents hydrogen atom or a lower alkyl group; W represents hydrogen atom or a lower alkyl group; R.sup.1 represents hydrogen atom, a lower alkyl group, phenyl group, a group shown by formula: --CH.sub.2 R.sup.4 in which R.sup.4 is a lower alkoxy group, or a group shown by formula: ##STR2## in which R.sup.5 and R.sup.6 are hydrogen atom or a lower alkyl group R.sup.2 represents hydrogen atom or a halogen atom; and R.sup.3 represents hydrogen atom, a lower alkyl group or a halogen atom; or a tautomer thereof; and pharmacologically acceptable salts thereof are disclosed. The 5-(6-imidazo[1,2-a]pyridyl)pyridine derivatives are effective for treating congestive heart failures.